# Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance

> **NCT06531863** · EARLY_PHASE1 · RECRUITING · sponsor: **Auburn University** · enrollment: 64 (estimated)

## Conditions studied

- Mood Disturbance

## Interventions

- **DIETARY_SUPPLEMENT:** Curcumin
- **DIETARY_SUPPLEMENT:** Epigallocatechin Gallate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06531863
- **Lead sponsor:** Auburn University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06531863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06531863, "Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06531863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*